These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34452625)

  • 1. The Anterior GRadient (AGR) family proteins in epithelial ovarian cancer.
    Fessart D; Robert J; Hartog C; Chevet E; Delom F; Babin G
    J Exp Clin Cancer Res; 2021 Aug; 40(1):271. PubMed ID: 34452625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models.
    Gray TA; MacLaine NJ; Michie CO; Bouchalova P; Murray E; Howie J; Hrstka R; Maslon MM; Nenutil R; Vojtesek B; Langdon S; Hayward L; Gourley C; Hupp TR
    J Immunol Methods; 2012 Apr; 378(1-2):20-32. PubMed ID: 22361111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of serum and tissue AGR2 for diagnosis and prognosis in epithelial ovarian cancer.
    Yan T; Wang H; Ma X; Cao J; Tong Y; Guo L; Lu R
    Biomark Med; 2023 Mar; 17(6):325-336. PubMed ID: 37284743
    [No Abstract]   [Full Text] [Related]  

  • 4. The Molecular Landscape Influencing Prognoses of Epithelial Ovarian Cancer.
    Liu CL; Yuan RH; Mao TL
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of AGR2 and AGR3 in cancer: similar but not identical.
    Obacz J; Takacova M; Brychtova V; Dobes P; Pastorekova S; Vojtesek B; Hrstka R
    Eur J Cell Biol; 2015; 94(3-4):139-47. PubMed ID: 25666661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNAs as prognostic and therapeutic tools in epithelial ovarian cancer.
    Nagaraj AB; Joseph P; DiFeo A
    Biomark Med; 2015; 9(3):241-57. PubMed ID: 25731210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Multimerin 1 (MMRN1) expression in ovarian cancer.
    Saini A; Chandra KB; Kumar V; Mathur SR; Sharma JB; Kumar S; Yadav S
    Mol Biol Rep; 2020 Dec; 47(12):9459-9468. PubMed ID: 33263168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of 4.1N in epithelial ovarian cancer results in EMT and matrix-detached cell death resistance.
    Wang D; Zhang L; Hu A; Wang Y; Liu Y; Yang J; Du N; An X; Wu C; Liu C
    Protein Cell; 2021 Feb; 12(2):107-127. PubMed ID: 32448967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
    Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
    Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer.
    King ER; Tung CS; Tsang YT; Zu Z; Lok GT; Deavers MT; Malpica A; Wolf JK; Lu KH; Birrer MJ; Mok SC; Gershenson DM; Wong KK
    Am J Surg Pathol; 2011 Jun; 35(6):904-12. PubMed ID: 21451362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Protein Biomarkers in Epithelial Ovarian Cancer Prognosis: An Aid for Multivariate Indexing.
    Paliwal P; Ranade H; Desai D; Datta M
    Curr Protein Pept Sci; 2021; 22(7):505-513. PubMed ID: 33568031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
    Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
    Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
    [No Abstract]   [Full Text] [Related]  

  • 13. Knockdown of ribosomal protein S6 suppresses proliferation, migration, and invasion in epithelial ovarian cancer.
    Yang X; Xu L; Yang YE; Xiong C; Yu J; Wang Y; Lin Y
    J Ovarian Res; 2020 Aug; 13(1):100. PubMed ID: 32862831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
    Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ
    Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic biomarkers in ovarian cancer.
    Huang J; Hu W; Sood AK
    Cancer Biomark; 2010-2011; 8(4-5):231-51. PubMed ID: 22045356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of Increased Expression of Annexin A10 (ANXA10) in Serous Epithelial Ovarian Cancer.
    Wang J; Zhao S; Wang F; Wang J; Zhang Y
    Med Sci Monit; 2019 Jul; 25():5666-5673. PubMed ID: 31363077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study.
    Brunette LL; Mhawech-Fauceglia PY; Ji L; Skeate JG; Brand HE; Lawrenson K; Walia S; Chiriva-Internati M; Groshen S; Roman LD; Kast WM; Da Silva DM
    BMC Cancer; 2018 Oct; 18(1):970. PubMed ID: 30309325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased PTOV1 expression is related to poor prognosis in epithelial ovarian cancer.
    Guo F; Feng L; Hu JL; Wang ML; Luo P; Zhong XM; Deng AM
    Tumour Biol; 2015 Jan; 36(1):453-8. PubMed ID: 25270739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and prognostic significance of caveolin-1 and ATG4C expression in the epithelial ovarian cancer.
    Zeng Y; Chen M; Ganesh S; Hu S; Chen H
    PLoS One; 2020; 15(5):e0232235. PubMed ID: 32401768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression levels and clinical significance of MFG-E8 and CD133 in epithelial ovarian cancer.
    Li N; Dai C; Yang Y; Wu X; Wang L; Wang P
    Gynecol Endocrinol; 2020 Sep; 36(9):803-807. PubMed ID: 31899997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.